|
|
Hill-Rom Clear Lungs™ Program
Prevention and treatment of ventilator-associated pneumonia
Ventilator-associated pneumonia (VAP) is the leading cause of death among hospital-acquired infections and has an associated mortality rate of 46%. Preventing pulmonary complications and treating existing conditions, like pneumonia are top of mind for caregivers and Hill-Rom.
The new Hill-Rom Clear Lungs Program enables measurable and sustainable reductions in pulmonary complications by:
- Enabling evidence-based continuous improvement of your pulmonary therapies, protocols and their adoption
- Automating VAP bundle protocols to ensure a raised head-of-bed angle and mobilization therapies, providing peace of mind for your patients and caregivers
- Better connecting the patient to the caregiver network
A comprehensive approach to reducing pulmonary complications
We understand that reducing respiratory infections in the ICU is difficult. It takes everyone in the care continuum to work together to administer proven therapies leveraging the right tools and technologies. Only Hill-Rom takes a comprehensive approach that includes:
- Actionable analytics to evaluate protocols and measure their adherence and effectiveness
- Clinical pulmonary experts and implementation teams that work side by side with you to establish the right treatments, therapies and protocols
- Broad portfolio of intelligent beds and surfaces that provide a full range of patient mobilization capabilities that are proven to reduce hospital LOS and facility-acquired pneumonia
- Centralized monitoring and proactive alerting of unsafe conditions, such as head-of-bed angle, directly to the caregiver- wherever they are.
- Almost 14,000 respiratory products, including over 6,000 ventilators available for rent 24 hours a day, 7 days a week.
|
